Skip to main content
MET
NYSE Finance

MetLife Reports Strong Q1 Earnings, Exceeding Estimates with 23% EPS Growth and $1.1B Capital Return

Analysis by Arik Shkolnikov
Sentiment info
Positive
Importance info
8
Price
$80.1
Mkt Cap
$52.269B
52W Low
$67.33
52W High
$83.85
Market data snapshot near publication time

summarizeSummary

MetLife reported strong first-quarter 2026 results, with adjusted EPS up 23% to $2.42, surpassing estimates, and returned over $1.1 billion to shareholders through repurchases and dividends.


check_boxKey Events

  • Strong Q1 Adjusted Earnings Beat

    Adjusted earnings per share increased 23% to $2.42, surpassing analyst estimates, with total adjusted earnings rising 18% to $1.6 billion for the quarter ended March 31, 2026.

  • Significant Capital Return to Shareholders

    MetLife returned over $1.1 billion to shareholders, including approximately $750 million in share repurchases and $370 million in common stock dividends during Q1 2026.

  • Robust Revenue and Segment Growth

    Premiums, fees, and other revenues (PFOs) increased 5% to $14.3 billion, with adjusted PFOs (excluding pension risk transfers) up 10% to $13.3 billion across all operating segments. Asia's adjusted earnings grew 31% and MetLife Investment Management's grew 68%.

  • Improved Profitability and Efficiency

    The adjusted Return on Equity (ROE) improved to 17.0%, and the direct expense ratio (excluding notable items and PRT) was 11.9%, ahead of the 12.1% annual target.


auto_awesomeAnalysis

MetLife's Q1 2026 results demonstrate robust financial health and operational efficiency, with adjusted earnings per share significantly beating analyst expectations. The substantial capital return to shareholders, comprising $750 million in share repurchases and $370 million in dividends, signals strong confidence from management and a commitment to shareholder value. The widespread growth across all segments, particularly in Asia and MetLife Investment Management, coupled with an improved adjusted ROE and a direct expense ratio ahead of target, indicates a well-executed strategy. This comprehensive positive performance, following recent news of an EPS beat, solidifies a bullish outlook for the company.

At the time of this filing, MET was trading at $80.10 on NYSE in the Finance sector, with a market capitalization of approximately $52.3B. The 52-week trading range was $67.33 to $83.85. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed MET - Latest Insights

MET
May 07, 2026, 5:09 PM EDT
Filing Type: 10-Q
Importance Score:
8
MET
May 06, 2026, 4:31 PM EDT
Filing Type: 8-K
Importance Score:
8
MET
May 06, 2026, 4:15 PM EDT
Source: Reuters
Importance Score:
8
MET
Apr 28, 2026, 4:18 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
MET
Apr 07, 2026, 6:11 AM EDT
Source: Reuters
Importance Score:
8
MET
Feb 26, 2026, 4:12 PM EST
Filing Type: 8-K
Importance Score:
7
MET
Feb 24, 2026, 4:46 PM EST
Filing Type: FWP
Importance Score:
8
MET
Feb 19, 2026, 4:34 PM EST
Filing Type: 10-K
Importance Score:
8
MET
Feb 04, 2026, 5:07 PM EST
Filing Type: 8-K
Importance Score:
8
MET
Jan 09, 2026, 6:53 AM EST
Filing Type: 8-K
Importance Score:
7